NM_001165963.4:c.3809A>C
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1PM2PP2PP3_StrongPP5_Moderate
The NM_001165963.4(SCN1A):c.3809A>C(p.Lys1270Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_001165963.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN1A | ENST00000674923.1 | c.3809A>C | p.Lys1270Thr | missense_variant | Exon 22 of 29 | NM_001165963.4 | ENSP00000501589.1 | |||
SCN1A | ENST00000303395.9 | c.3809A>C | p.Lys1270Thr | missense_variant | Exon 21 of 28 | 5 | ENSP00000303540.4 | |||
SCN1A | ENST00000375405.7 | c.3776A>C | p.Lys1259Thr | missense_variant | Exon 19 of 26 | 5 | ENSP00000364554.3 | |||
SCN1A | ENST00000409050.1 | c.3725A>C | p.Lys1242Thr | missense_variant | Exon 19 of 26 | 5 | ENSP00000386312.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
The c.3809A>C (p.K1270T) alteration is located in exon 19 (coding exon 19) of the SCN1A gene. This alteration results from a A to C substitution at nucleotide position 3809, causing the lysine (K) at amino acid position 1270 to be replaced by a threonine (T). for autosomal dominant SCN1A-related seizure disorders; however, its clinical significance for autosomal dominant SCN1A-related hemiplegic migraine is uncertain. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This variant was identified in one or more individuals with features consistent with SCN1A-related seizure disorders and segregated with disease in at least one family (Abou-Khalil, 2001). This amino acid position is highly conserved in available vertebrate species. Animal models expressing this variant exhibited phenotype(s) consistent with SCN1A-related seizure disorders (Das, 2021; Sun, 2012; Schutte, 2014). In multiple assays testing SCN1A function, this variant showed functionally abnormal results (Xie, 2020). This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic. -
Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
This sequence change replaces lysine, which is basic and polar, with threonine, which is neutral and polar, at codon 1270 of the SCN1A protein (p.Lys1270Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with generalized epilepsy with febrile seizures plus (GEFS+) (PMID: 11756608). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 12891). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt SCN1A protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
Generalized epilepsy with febrile seizures plus, type 2 Pathogenic:1
- -
Generalized epilepsy with febrile seizures plus, type 1 Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at